In the gastrointestinal tract, studies have been conducted on ERBB2-mutant gastric cancer (GC) and colorectal cancer (CRC) [4,5]; however, none have comprehensively examined ERBB2-mutant esophageal adenocarcinoma (EAC). Here, ERBB2 is linked to colorectal carcinoma.